Justin K. Lui MD, MS

Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine

Member, Pulmonary Center

72 E. Concord Street | (617) 358-2800
Justin Lui
Sections

Pulmonary, Allergy, Sleep & Critical Care Medicine

Biography

Dr. Lui is a Pulmonary and Critical Care physician and an Assistant Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine. Dr. Lui's clinical and research interest is in pulmonary hypertension, specifically in systemic sclerosis. Within the Pulmonary Center, he conducts clinical and translational research that is at the intersection of medicine and engineering in applying advanced data science approaches for a deep cardiopulmonary phenotyping of this rare disease population to further advance novel diagnostic and therapeutic approaches.

In addition to his research interests, Dr. Lui is passionate about teaching clinical reasoning, trainee career development, and interprofessional education.

Education

MD, Boston University School of Medicine

MS, Boston University School of Public Health

Publications

Published on 5/8/2023

Wong DH, Lui JK. Telehealth and virtual learning. Clin Teach. 2023 May 08; e13581. PMID: 37157137.

Published on 1/23/2023

El-Adili F, Lui JK, Najem M, Farina G, Trojanowska M, Sam F, Bujor AM. Correction: Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications. Arthritis Res Ther. 2023 Jan 23; 25(1):11. PMID: 36691037.

Published on 1/20/2023

Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 20. PMID: 36662449.

Published on 1/6/2023

Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 06. PMID: 36607535.

Published on 11/29/2022

Lui JK, Duke JD, Russo JV, Kelm DJ, Hinkle LJ. Multisource feedback in health professions education. Clin Teach. 2023 Feb; 20(1):e13555. PMID: 36446412.

Published on 11/11/2022

El-Adili F, Lui JK, Najem M, Farina G, Trojanowska M, Sam F, Bujor AM. Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications. Arthritis Res Ther. 2022 Nov 11; 24(1):251. PMID: 36369212.

Published on 10/1/2022

Sangani RA, Lui JK, Gillmeyer KR, Trojanowski MA, Bujor AM, LaValley MP, Klings ES. Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity. Pulm Circ. 2022 Oct; 12(4):e12117. PMID: 36238967.

Published on 6/9/2022

Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2022 Jun 09. PMID: 35678779.

Published on 4/5/2022

Lui JK, Sangani RA, Chen CA, Bujor AM, Trojanowski MA, Gopal DM, LaValley MP, Soylemez Wiener R, Klings ES. Prognostic Value of Cardiac Axis Deviation in Systemic Sclerosis-Related Pulmonary Hypertension. Arthritis Care Res (Hoboken). 2022 Jul; 74(7):1219-1226. PMID: 34085410.

Published on 4/1/2022

Walsh KF, Lui JK. Post-tuberculosis pulmonary hypertension: a case of global disparity in health care. Lancet Glob Health. 2022 04; 10(4):e476. PMID: 35303453.

View full list of 32 publications.